Pseudotyped Viruses: A Useful Platform for Pre-Clinical Studies Conducted in a BSL-2 Laboratory Setting
Open Access
- 15 January 2025
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 15 (1) , 135
Abstract
The study of pathogenic viruses has always posed significant biosafety challenges. In particular, the study of highly pathogenic viruses requires methods with low biological risk but relatively high sensitivity and convenience in detection. In recent years, pseudoviruses, which consist of a backbone of one virus and envelope proteins of another virus, have become one of the most widely used tools for exploring the mechanisms of viruses binding to cells, membrane fusion and viral entry, as well as for screening the libraries of antiviral substances, evaluating the potential of neutralizing monoclonal antibodies, developing neutralization tests, and therapeutic platforms. During the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), pseudotyped virus-based assays played a pivotal role in advancing our understanding of virus–cell interactions and the role of its proteins in disease pathogenesis. Such tools facilitated the search for potential therapeutic agents and accelerated epidemiological studies on post-infection and post-vaccination humoral immunity. This review focuses on the use of pseudoviruses as a model for large-scale applications to study enveloped viruses.Keywords
Funding Information
- Russian Science Foundation (24-25-20139)
This publication has 142 references indexed in Scilit:
- Dual Assay Validation of Rosmarinus officinalis Extract as an Inhibitor of SARS‐CoV‐2 Spike Protein: Combining Pseudovirus Testing, Yeast Two‐Hybrid, and UPLC‐Q Exactive Orbitrap‐MS ProfilingPhytochemical Analysis, 2024
- Evaluation of cross‐neutralizing immunity following COVID‐19 primary series vaccination during the Omicron surge in TanzaniaJournal of Medical Virology, 2024
- Nanoengineered Red Blood Cells Loaded with TMPRSS2 and Cathepsin L Inhibitors Block SARS‐CoV‐2 Pseudovirus Entry into Lung ACE2+ CellsAdvanced Materials, 2024
- A potential broad‐spectrum neutralizing antibody against BetacoronavirusJournal of Medical Virology, 2023
- SARS‐CoV‐2 pseudovirus infectivity and expression of viral entry‐related factors ACE2, TMPRSS2, Kim‐1, and NRP‐1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systemsJournal of Medical Virology, 2021
- Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS‐CoV‐2 Neutralizing AntibodiesCurrent Protocols in Immunology, 2020
- Recombinant Viral Vectors as Neuroscience ToolsCurrent Protocols in Neuroscience, 2019
- A cell-based high-throughput protocol to screen entry inhibitors of highly pathogenic viruses with Traditional Chinese MedicinesJournal of Medical Virology, 2016
- Identification of a high affinity nucleocapsid protein binding element within the moloney murine leukemia virus Ψ-RNA packaging signal: implications for genome recognitionJournal of Molecular Biology, 2001
- Infectious rabies viruses from cloned cDNA.The EMBO Journal, 1994